A business in context

OBIO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-01 · 0001104659-26-113320

  2. 8-K · Current report

    Report date 2026-10-01 · 0001104659-26-112586 · Items 7.01,8.01,9.01

  3. 4 · Ownership change

    Report date 2026-09-10 · 0001104659-26-107143

  4. 8-K · Current report

    Report date 2026-09-08 · 0001104659-26-105733 · Items 7.01,9.01

  5. 4 · Ownership change

    Report date 2026-09-03 · 0001104659-26-105690

  6. 4 · Ownership change

    Report date 2026-09-01 · 0001104659-26-104739

  7. 4 · Ownership change

    Report date 2026-08-26 · 0001104659-26-103210

  8. 4 · Ownership change

    Report date 2026-08-26 · 0001104659-26-103209

  9. 4 · Ownership change

    Report date 2026-08-26 · 0001104659-26-103205

  10. 4 · Ownership change

    Report date 2026-08-12 · 0001104659-26-097195

  11. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-093357

  12. 8-K · Current report

    Report date 2026-06-23 · 0001104659-26-076845 · Items 5.07

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-059382

  14. DEF 14A · Proxy statement

    Report date 2026-06-23 · 0001104659-26-051570

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-026754

  16. 8-K · Current report

    Report date 2026-02-12 · 0001104659-26-015315 · Items 5.02

  17. 8-K · Current report

    Report date 2026-01-12 · 0001104659-26-002752 · Items 8.01,9.01

  18. 8-K · Current report

    Report date 2025-11-12 · 0001104659-25-110907 · Items 7.01,9.01

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-109128

  20. 8-K · Current report

    Report date 2025-10-30 · 0001104659-25-104016 · Items 7.01,9.01

  21. 8-K · Current report

    Report date 2025-10-24 · 0001104659-25-102862 · Items 1.01,1.02,3.02,7.01,8.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-011148

  23. 8-K · Current report

    Report date 2025-07-31 · 0001104659-25-073641 · Items 1.01,7.01,8.01,9.01

  24. 8-K · Current report

    Report date 2025-07-31 · 0001104659-25-072678 · Items 1.01,2.03,3.02,7.01,8.01,9.01

  25. 8-K · Current report

    Report date 2025-06-24 · 0001104659-25-062105 · Items 5.07

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-007373

  27. DEF 14A · Proxy statement

    Report date 2025-06-24 · 0001104659-25-042530

  28. 8-K · Current report

    Report date 2025-04-29 · 0001104659-25-040763 · Items 7.01,8.01,9.01

  29. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-004161

  30. 8-K · Current report

    Report date 2025-03-03 · 0001104659-25-019500 · Items 7.01,9.01

  31. 8-K · Current report

    Report date 2025-02-19 · 0001104659-25-016950 · Items 5.02

  32. 8-K · Current report

    Report date 2025-01-30 · 0001104659-25-009393 · Items 5.02,7.01,9.01

  33. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001558370-24-015313

  34. SC 13G · Ownership disclosure

    0002012383-24-003380

  35. SC 13G · Ownership disclosure

    0002012383-24-001849

  36. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001558370-24-011899

  37. 8-K · Current report

    Report date 2024-08-12 · 0001104659-24-088431 · Items 8.01,9.01

  38. SC 13D/A · Ownership disclosure

    0001193125-24-196045

  39. SC 13D/A · Ownership disclosure

    0001193125-24-196038

  40. 8-K · Current report

    Report date 2024-07-29 · 0001104659-24-083973 · Items 5.02,7.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 2 transaction rows2PSale: 3 transaction rows3SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 9 transaction rows9FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

14 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-10
2026-09-11
Hochman David PF · Tax / exercise payment
Disposed
Common Stock3283.05.81
2026-09-10
2026-09-11
Hochman David PF · Tax / exercise payment
Disposed
Common Stock, par value $0.0001 per share ("Common Stock")3283.05.81
2026-09-03
2026-09-08
Hochman David PP · Purchase
Acquired
Common Stock, par value $0.0001 per share ("Common Stock")10000.04.79
2026-09-01
2026-09-02
Sherman Darren
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock, par value $0.0001 per share ("Common Stock")15000.04.94
2026-08-26
2026-08-28
Taylor Andrew LawrenceF · Tax / exercise payment
Disposed
Common Stock, par value $0.0001 per share3076.05.26
2026-08-26
2026-08-28
Sherman DarrenF · Tax / exercise payment
Disposed
Common Stock, par value $0.0001 per share ("Common Stock")4925.05.26
2026-08-26
2026-08-28
Sherman DarrenP · Purchase
Acquired
Common Stock2000.05.33
2026-08-26
2026-08-28
Aiello JoshuaF · Tax / exercise payment
Disposed
Common Stock, par value $0.0001 per share203.05.26
2026-08-12
2026-08-14
Pacitti DavidF · Tax / exercise payment
Disposed
Common Stock, par value $0.0001 per share3761.04.42
2026-08-12
2026-08-14
Fain Eric SF · Tax / exercise payment
Disposed
Common Stock, par value $0.0001 per share5145.04.42
2026-08-12
2026-08-14
Mack John ProsperF · Tax / exercise payment
Disposed
Common Stock, par value $0.0001 per share4885.04.42
2026-08-12
2026-08-14
Cleary ChrisF · Tax / exercise payment
Disposed
Common Stock, par value $0.0001 per share4238.04.42
2026-08-03
2026-08-04
Sherman Darren
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock, par value $0.0001 per share15000.04.09
2026-07-01
2026-07-02
Sherman Darren
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock, par value $0.0001 per share15000.04.27

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001814114Orchestra BioMed Holdings, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • Health Sciences Acquisitions Corp 2 · former SEC name · 2020-06-22 to 2023-01-26

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$2.64M$2.83M
2023-12-31$2.76M$3.05M
2022-12-31$3.53M$4.07M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗